Alveolar surface tension and surfactant

31,821views

Alveolar surface tension and surfactant

Cardiothoracic Disease

Cardiothoracic Disease

Respiratory system anatomy and physiology
Lung volumes and capacities
Anatomic and physiologic dead space
Ventilation
Alveolar gas equation
Compliance of lungs and chest wall
Combined pressure-volume curves for the lung and chest wall
Alveolar surface tension and surfactant
Airflow, pressure, and resistance
Breathing cycle
Breathing control
Pulmonary chemoreceptors and mechanoreceptors
Ideal (general) gas law
Boyle's law
Dalton's law
Henry's law
Fick's laws of diffusion
Graham's law
Diffusion-limited and perfusion-limited gas exchange
Hypoxia
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Erythropoietin
Carbon dioxide transport in blood
Regulation of pulmonary blood flow
Zones of pulmonary blood flow
Pulmonary shunts
Ventilation-perfusion ratios and V/Q mismatch
Pulmonary changes during exercise
Pulmonary changes at high altitude and altitude sickness
Diffuse parenchymal lung disease: Clinical
Restrictive lung diseases: Pathology review
Restrictive lung diseases
Idiopathic pulmonary fibrosis
Sarcoidosis
Lung cancer: Clinical
Lung cancer and mesothelioma: Pathology review
Mesothelioma
Cardiovascular system anatomy and physiology
Lymphatic system anatomy and physiology
Cardiac cycle
Normal heart sounds
Abnormal heart sounds
Blood pressure, blood flow, and resistance
Resistance to blood flow
Laminar flow and Reynolds number
Compliance of blood vessels
Pressures in the cardiovascular system
Physiological changes during exercise
Cardiovascular changes during hemorrhage
Cardiovascular changes during postural change
Measuring cardiac output (Fick principle)
Cardiac and vascular function curves
Altering cardiac and vascular function curves
Stroke volume, ejection fraction, and cardiac output
Frank-Starling relationship
Pressure-volume loops
Changes in pressure-volume loops
Cardiac work
Cardiac preload
Cardiac afterload
Law of Laplace
Baroreceptors
Renin-angiotensin-aldosterone system
Chemoreceptors
Cardiac conduction system
Action potentials in pacemaker cells
Action potentials in myocytes
Cardiac conduction velocity
Excitability and refractory periods
Cardiac excitation-contraction coupling
Cardiac contractility
Cerebral circulation
Coronary circulation
Control of blood flow circulation
Microcirculation and Starling forces
Cardiomyopathies: Clinical
Cardiomyopathies: Pathology review
Hypertrophic cardiomyopathy
Dilated cardiomyopathy
Restrictive cardiomyopathy
Sleep apnea
Apnea of prematurity
Aortic aneurysms and dissections: Clinical
Aortic dissections and aneurysms: Pathology review
Aortic dissection
Aneurysms
Marfan syndrome
Peripheral vascular disease: Clinical
Peripheral artery disease: Pathology review
Peripheral artery disease
Arterial disease
Deep vein thrombosis
Leg ulcers: Clinical
Chronic venous insufficiency
Thrombophlebitis
Vasculitis: Pathology review
Vasculitis
Kawasaki disease
Behcet's disease
Nutcracker syndrome
Superior mesenteric artery syndrome
Subclavian steal syndrome
Coronary steal syndrome
Lymphedema
ECG basics
ECG normal sinus rhythm
ECG rate and rhythm
ECG intervals
ECG axis
ECG QRS transition
ECG cardiac hypertrophy and enlargement
ECG cardiac infarction and ischemia
Heart blocks: Pathology review
Premature ventricular contraction
Premature atrial contraction
Atrial fibrillation
Atrial flutter
Atrioventricular nodal reentrant tachycardia (AVNRT)
Wolff-Parkinson-White syndrome
Atrioventricular block
Bundle branch block
Long QT syndrome and Torsade de pointes
Ventricular tachycardia
Brugada syndrome
Ventricular fibrillation
Pulseless electrical activity
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Positive inotropic medications
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
Adrenergic antagonists: Presynaptic
cGMP mediated smooth muscle vasodilators
Calcium channel blockers
Heart failure: Clinical
Heart failure: Pathology review
Heart failure
Cor pulmonale
Pulmonary hypertension
Pulmonary edema
Anatomy of the coronary circulation
Asthma: Clinical
Obstructive lung diseases: Pathology review
Asthma
Chronic obstructive pulmonary disease (COPD): Clinical
Chronic bronchitis
Emphysema
Alpha 1-antitrypsin deficiency
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Non-corticosteroid immunosuppressants and immunotherapies
Cystic fibrosis: Pathology review
Cystic fibrosis
Bronchiectasis
Anatomy of the heart
Anatomy clinical correlates: Heart
Cardiac muscle histology
Marfan syndrome
Ehlers-Danlos syndrome
Arteriole, venule and capillary histology
Cardiac muscle histology
Artery and vein histology
Trachea and bronchi histology
Bronchioles and alveoli histology
Nasal cavity and larynx histology
Coarctation of the aorta
Mitral valve disease
Pulmonary valve disease
Tricuspid valve disease
Aortic valve disease
Ventricular arrhythmias: Pathology review
Supraventricular arrhythmias: Pathology review
Coronary artery disease: Clinical
Atherosclerosis and arteriosclerosis: Pathology review
Coronary artery disease: Pathology review
Arterial disease
Angina pectoris
Unstable angina
Myocardial infarction
Prinzmetal angina
Coronary steal syndrome

Flashcards

Alveolar surface tension and surfactant

0 of 15 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 2 complete

A researcher is studying pulmonary physiology. He identifies a substance secreted by type II pneumocytes that is composed primarily of lipoproteins. This substance will likely have which of the following effects on pulmonary physiology?  

Transcript

Watch video only

The alveoli are the tiny air sacs in the lungs where gas exchange happens. And their walls are lined by a thin film of water, which creates a force at their surface called surface tension.

Surface tension tends to collapse the pulmonary alveoli, and, as you can imagine, this could turn into a big problem - not being able to breathe in.

Luckily, alveolar cells have found a way to counteract surface tension by producing surfactant, which is a phospholipoprotein that reduces the surface tension, keeping the alveoli open so that we can breathe properly.

That being said, take a deep breath, because we’re about to delve into the physics of surface tension.

The water molecules, known as H2O to their friends, stay close together because of hydrogen bonds that form between the negatively charged oxygen ion of one molecule and the positively charged hydrogen ion of another molecule.

Within the bulk of water, the molecules are equally pulled in every direction by neighboring molecules, so the resulting net force is zero.

However, when you add air into the mix, the whole system becomes unbalanced, because at the water-air interface, water molecules are not surrounded by other water molecules.

This creates too many cohesive forces between water molecules at the surface, that pull the water molecules at the surface closer together, making the surface of the water shrink to the minimum surface area possible.

Now, the interior of the alveoli is also spherical, so the net force of surface tension is directed to the center of the alveoli, which tends to collapse the alveolar walls towards the center.

The magnitude of this force is predicted by Laplace law, which states that the pressure collapsing the alveolus is directly proportional to the surface tension generated by molecules of fluid lining the alveolus, and inversely proportional to the radius of the alveoli. So the smaller the alveoli, the larger the collapsing pressure.

Now, when we breathe out, alveolar size decreases, because the air that was inflating it is now expelled from the lungs.

This means that the alveolar radius reduces, which increases the collapsing pressure according to Laplace.

It also means that for inspiration to occur – which is literally trying to inflate the alveoli, it will take too much force to first overcome this collapsing pressure, meaning the entire inspiration process will be quite difficult.

Difficulty in inflating individual lung alveoli results in reduced lung compliance, which is the ability of the lung to stretch and inflate as a whole.

Luckily enough, this doesn’t happen in normal individuals, because human alveoli synthesize a lipoprotein compound called pulmonary surfactant.

The surfactant lines the alveolar walls over the water film, and then reduces the surface tension and thus the collapsing pressure.

Diving deep into this, let’s zoom in and look at a cross-section of the wall of the pulmonary alveoli. It largely consists of type I pneumocytes, which are flat squamous epithelial cells.

These cells are very thin and widespread making up to 97 % of the whole alveolar surface, which ensures an efficient diffusion needed in gas exchange between the alveoli and blood within a surrounding capillary network.

Next to type I pneumocytes lies type II pneumocytes, which are cuboidal cells that contain lamellar bodies - the organelles that secrete pulmonary surfactant.

In humans, lamellar bodies start producing surfactant at 24 to 28 weeks of gestational age, and usually by the week of 35, alveoli have enough surfactant to keep them from collapsing.

Now, let's have a look at the pulmonary surfactant itself. It is a phospholipoprotein complex, consisting mainly of Dipalmitoyl phosphatidylcholine or just DPPC, and some proteins such as surfactant proteins – A and D.

Key Takeaways

Alveolar surface tension is the tension that results from the forces acting on the liquid surfaces of the alveoli. The primary force acting on the liquid surface is due to the cohesive forces between neighboring water molecules.

These forces are called "hydrogen bonds" and they are responsible for water's unique properties, such as its ability to form droplets ( rain, dew, etc.). Surface tension tends to collapse the alveoli, but this is countered by a kind of "coating" that covers the alveolar surface called surfactant. Surfactant reduces the surface tension of water, keeping the alveoli open so that we can breathe easily.

Sources

  1. "Medical Physiology" Elsevier (2016)
  2. "Physiology" Elsevier (2017)
  3. "Human Anatomy & Physiology" Pearson (2018)
  4. "Principles of Anatomy and Physiology" Wiley (2014)
  5. "Beyond Navier–Stokes equations: capillarity of ideal gas" Contemporary Physics (2016)
  6. "Host Defense Functions of Pulmonary Surfactant" Neonatology (2004)
  7. "Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study" JAMA Pediatrics (2013)